In a breakthrough clinical trial undertaken by Australian biotechnology company Marinova, a unique seaweed extract has been shown to relieve the symptoms of benign prostatic hyperplasia (BPH). HOBART, Australia, July 27, 2026 /PRNewswire/ -- A randomised, double-blind, placebo-controlled clinical trial evaluated the effects of fucoidan, a naturally occurring compound found in brown seaweed, on men with BPH (prostate enlargement). Undaria pinnatifida seaweed - the source of Marinova's high purity fucoidan compounds. BPH is a common health issue for men across the globe. Worldwide estima…READ FULL ARTICLE
